Critical Review: Interventional Neuroradiology Journal [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.
====== Critical Review: Interventional Neuroradiology Journal ======

=== 📊 Journal Profile & Impact ===
  * **Publisher & Frequency**: Published by SAGE (Centauro SRL, Italy) in association with the World Federation of Interventional and Therapeutic Neuroradiology. Bimonthly since 1995.
  * **Impact Factor & Ranking**:
    * Clarivate Impact Factor (2021): ~1.76
    * Scopus CiteScore (2023): ~1.59
    * Scimago SJR (2023): 0.543 (Q2)
    * h-index: ~44

  These metrics place INR in the mid-tier (Q2) among neuroradiology journals.

=== 🧪 Strengths ===
  - **Focused Scope**: Excels at case reports, novel techniques, and translational studies in interventional neuroradiology.
  - **International Editorial Board**: Members from Mayo Clinic, Oxford, Tokyo, etc.
  - **Ethical Standards**: Member of COPE (Committee on Publication Ethics).

=== ⚠️ Areas for Improvement ===
  - **Modest Citation Impact**: Lower than top-tier journals such as JNIS or *Neuroradiology*.
  - **Few High-Level Trials**: Mostly observational studies; rare randomized controlled trials.
  - **Quality Variability**: Some studies with limited statistical or methodological robustness.

=== 🔍 Comparative Context ===
Compared to journals like:
  * ''Journal of NeuroInterventional Surgery'' (IF ~4.5)
  * ''Neuroradiology'' (IF ~2.6)

INR has less international prestige. Landmark clinical trials often appear in general medical journals like ''NEJM'', ''Lancet'', or ''JAMA''.

=== ✅ Final Evaluation ===

^ Feature ^ Strength ^ Limitation ^
| Specialty Focus | High | Narrow scope |
| Peer Review & Ethics | COPE membership | Some technical/statistical issues |
| Clinical Trials | Accepts early-stage innovations | RCTs often published elsewhere |
| Prestige | Q2 | Lower visibility vs top neuro journals |

**Overall**: A respected, specialized journal ideal for technique-oriented studies, early innovation, and practical interventional insights.

=== 🛠 Suggestions ===
  * **Authors**: Ideal for pilot data, case series, and technical reports. For large-scale trials, consider higher-impact venues.
  * **Readers**: Useful for staying current with procedural advances. Supplement with broader-evidence journals for guidelines and trials.

----
[[https://journals.sagepub.com/home/ine|Official Website – Interventional Neuroradiology (SAGE)]]